Glycine (Hospira, Inc.)


Welcome to the PulseAid listing for the Glycine drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: GLYCINE
SUBSTANCE NAME: GLYCINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: IRRIGATION
DOSAGE FORM: IRRIGANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-07-27
END MARKETING DATE: 0000-00-00


Glycine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGlycine from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.5(g/100mL)
START MARKETING DATE: 2005-07-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-7974_59b17b67-16c3-4e38-9862-f50b9975de8f
PRODUCT NDC: 0409-7974
APPLICATION NUMBER: NDA018315

Other GLYCINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Glycine
Baxter Healthcare CorporationGlycine
Hospira, Inc.Glycine